Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
NCT07616973 Clomiphene Citrate Infertility Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07616973 clinical trial report covering Clomiphene Citrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
ChiCTR2600125798 Enzalutamide Metastatic castration-resistant prostate cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600125798 clinical trial report covering Enzalutamide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07616375 HSK-31858 Non-cystic fibrosis bronchiectasis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07616375 clinical trial report covering HSK-31858, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
ChiCTR2600125844 Albumin-Bound Paclitaxel Locally Advanced Cervical Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600125844 clinical trial report covering Albumin-Bound Paclitaxel, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
ChiCTR2600125893 Remimazolam Tosylate Neoplasms Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600125893 clinical trial report covering Remimazolam Tosylate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07617870 Recombinant human prourokinase Ischemic Attack, Transient Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07617870 clinical trial report covering Recombinant human prourokinase, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07619131 Rosuvastatin Calcium Hypercholesterolemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07619131 clinical trial report covering Rosuvastatin Calcium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07619118 Rosuvastatin Calcium Hypercholesterolemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07619118 clinical trial report covering Rosuvastatin Calcium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07618806 Amlodipine Besylate Tumescence Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07618806 clinical trial report covering Amlodipine Besylate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20261932 Eloralintide Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261932 clinical trial report covering Eloralintide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262081 HY-072808 Chronic hand eczema Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20262081 clinical trial report covering HY-072808, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20261945 Chaijin Jieyu Anshen Tablets Depressive Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261945 clinical trial report covering Chaijin Jieyu Anshen Tablets, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
237
238
239
240
241
>>
739
>